Request a Meeting

Meet DES Pharma Consulting at ASGCT 2026

Connect with DES experts to discuss CMC, analytical readiness, supply chain execution, quality, and safety strategy for advanced therapy and biologics programs.

Request a Meeting
Book via Calendly
Meet the Principals
Dates

May 11–15, 2026

Location

Boston, Massachusetts

Event

ASGCT Annual Meeting

Meeting Request

Schedule time with DES at ASGCT

DES can route requests to the most relevant principal based on modality, function, and program needs.

Prefer to book instantly? Schedule directly via Calendly

About the ASGCT Annual Meeting

The American Society of Gene and Cell Therapy Annual Meeting is the premier event for professionals across gene and cell therapy. It brings together scientists, clinicians, biotech and pharmaceutical leaders, regulatory stakeholders, manufacturers, and industry partners to share the latest research, explore new technologies, and build meaningful connections across the field.

Originally established as a forum for academic researchers, the meeting has grown into a broad industry gathering spanning discovery through commercialization. It is one of the best places to stay current on science, regulation, and operational strategy while connecting with peers across the advanced therapy ecosystem.
For registration and more information, visit annualmeeting.asgct.org.

Meet with DES at ASGCT

DES Pharma Consulting is a specialized biopharmaceutical consulting firm focused on accelerating the development, manufacturing, and commercialization of advanced therapies. Founded by industry leaders with deep experience across CMC, analytical development, supply chain, and safety, DES helps biotech and pharma teams reduce risk, improve execution, and move programs forward with confidence.

The team has supported programs from preclinical development through commercial launch across cell and gene therapies, biologics, and complex modalities, bringing practical hands-on expertise to critical decisions across the product lifecycle.

Process Development & CMC

Analytical Development & QC

Supply Chain & Procurement

Quality, Compliance & Readiness

Pharmacovigilance & Medical Safety

Technical Transfer & Commercialization Support

Who you’ll meet

Connect directly with DES principals aligned to your program’s CMC, analytical, supply chain, quality, and safety priorities.

Meade Medaugh, P.E.

Founding Member | Principal Consultant, Process Development & CMC
Process, CMC & Regulatory Strategy

Bioprocess design, scale-up, and IND-enabling CMC strategy across advanced therapy and biologics programs.

  • Process development and scale-up
  • CMC strategy and manufacturing readiness
  • Tech transfer and cost-of-goods optimization

Jeannine Larrieux

Principal Consultant, Analytical Development & QC
Analytical & QC Strategy
Analytical development, quality systems, regulatory submissions, comparability, and lifecycle management across complex modalities.
  • Analytical method development and qualification
  • Comparability, stability, and release strategy
  • Quality compliance and FDA 483 remediation

Isaac G. Jeganathan

Founding Member | Principal Consultant, Supply Chain & Procurement
CDMO & Supply Chain Strategy
Global supply chain leadership spanning CDMO oversight, technology transfer, procurement, and network optimization.
  • CDMO selection and oversight
  • Global tech transfer and launch execution
  • Procurement, ERP, and network optimization

Gladys Joa, Pharm.D.

Principal Consultant, Pharmacovigilance & Safety
Safety & PV Strategy
End-to-end pharmacovigilance and medical safety expertise from first-in-human studies through post-market readiness.
  • Signal detection and safety governance
  • Aggregate reports, RMPs, and submissions
  • Global medical safety systems and cross-functional leadership